drugset / Trial / NCT01017796

Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients

NCT01017796

Phase 0 Unknown 100 enrolled University of Thessaly
RandomizedParallel-groupSingle-blindPrevention

Summary

The use of N-acetylcysteine and ascorbic acid reduce the incidence of radiographic contrast agent induced reduction in renal function in Intensive Care Unit patients.

Timeline

Start
2009-01
Primary completion
2010-01
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg Intravenous
Subject Vitamin C Other / unclassified 1.5 g Intravenous